The gut-brain axis: clinical implications for cognitive health
The idea that the gut and brain communicate is no longer fringe physiology. It is now one of the most rapidly developing areas in neuroscience and clinical medicine.
After 25 years in practice - across NHS medicine, chronic disease management and now cognitive focused lifestyle medicine - the evidence has become impossible to ignore: the gut plays a meaningful role in brain health, including
dementia risk.
The gut–brain axis: a bidirectional communication system
The gut and brain communicate through several pathways:
the vagus nerve, which carries afferent signals from the gut to the brain
the immune system, particularly cytokine signalling
microbial metabolites, including shortchain fatty acids (SCFAs)
the hypothalamic–pituitary–adrenal (HPA) axis, linking stress and gut function
This network is collectively known as the gut–brain axis. Far from being a theoretical construct, it is supported by decades of neurogastroenterology research.
A landmark review in Nature Reviews Gastroenterology & Hepatology describes the vagus nerve as a “major highway” for gutderived signals influencing mood, cognition and neuroinflammation. Animal studies show that severing the vagus nerve can block microbiomerelated behavioural changes, highlighting its central role.
Microbiome dysbiosis and cognitive decline
Dysbiosis - an imbalance in gut microbial composition—has been linked to several neurological conditions, including:
Alzheimer’s disease
Parkinson’s disease
mild cognitive impairment
depression and anxiety
neuroinflammatory disorders
A 2023 metaanalysis in Alzheimer’s & Dementia found consistent differences in the gut microbiota of people with Alzheimer’s disease, including reduced SCFAproducing bacteria and increased proinflammatory species.
Mechanisms proposed include:
increased gut permeability (“leaky gut”)
systemic inflammation
microglial activation
altered production of neuroactive metabolites
impaired vagal signalling
While causation is not fully established, the association is strong enough that several dementia research groups now consider the microbiome a modifiable risk factor.
The vagus nerve: inflammation, mood and cognition
The vagus nerve is the primary neural pathway linking the gut and brain. It influences:
inflammatory tone
autonomic balance
stress responses
mood regulation
cognitive performance
Vagal tone is reduced in chronic stress, metabolic disease and inflammatory conditions—all of which are also dementia risk factors.
Emerging evidence suggests that vagal stimulation (invasive and noninvasive) may improve cognitive outcomes in early Alzheimer’s disease, although trials remain small. The mechanism is thought to involve reduced neuroinflammation and improved neural plasticity.
What functional medicine contributes
(when practised responsibly)
Functional medicine is often criticised for overinterpreting early evidence. Some of that criticism is justified. However, when grounded in peerreviewed research, it offers a useful systemsbiology lens.
Evidencesupported interventions that may influence the gut–brain axis include:
A. Dietary fibre and SCFA production
Highfibre diets increase SCFAproducing bacteria. SCFAs such as butyrate have antiinflammatory and neuroprotective effects. Cohort studies link higher fibre intake with lower dementia risk.
B. Mediterraneanstyle dietary patterns
The MIND and Mediterranean diets—both rich in polyphenols, fibre and healthy fats—are associated with slower cognitive decline. These diets also promote microbial diversity.
C. Targeted probiotics
Small RCTs show that certain probiotic strains may improve cognitive scores in mild cognitive impairment, though effects are modest and strainspecific.
D. Reducing metabolic inflammation
Insulin resistance and visceral adiposity alter gut microbiota and increase systemic inflammation. Lifestyle interventions that improve metabolic health may indirectly support cognitive resilience.
E. Stress reduction and vagal tone
Breathwork, meditation and physical activity have been shown to increase vagal tone. While not dementia treatments, they may influence the inflammatory pathways relevant to cognitive ageing.
Functional medicine’s strength lies in integrating these domains rather than treating them as isolated variables.
The gut–brain axis and dementia: what we know
so far
The evidence linking gut health and dementia is growing but still developing. Key findings include:
People with Alzheimer’s disease consistently show reduced microbial diversity.
Dysbiosis correlates with higher levels of peripheral inflammatory markers.
SCFA levels are lower in individuals with cognitive impairment.
Animal models show that altering the microbiome can influence amyloid and tau pathology.
Early human trials suggest that modifying the microbiome may improve cognitive scores, though effects are small and not yet clinically transformative.
The most important point is this: the gut–brain axis is not a cure for dementia, but it is a meaningful piece of the puzzle.
Clinical implications for practice
For us as clinicians working in cognitive health, the gut–brain axis offers several practical considerations:
Symptoms such as bloating, IBStype discomfort, or altered bowel habits may be relevant to cognitive complaints.
Lifestyle interventions that support gut health often overlap with those known to reduce dementia risk.
Patients with chronic stress, poor sleep or metabolic dysfunction may have impaired vagal signalling.
Microbiome testing remains inconsistent in quality; clinical decisions should not rely on it alone.
Interventions should be evidencealigned, not speculative.
The goal is not to replace standard dementia pathways, but to enhance them with a broader understanding of systemic physiology.
Conclusion: A systems-based view of cognitive health
The gut–brain axis is not alternative medicine. It is emerging neuroscience. While the field is still evolving, the evidence already suggests that gut health, inflammation, metabolic function and vagal signalling all contribute to cognitive ageing.
For patients and clinicians alike, this offers a hopeful message: cognitive health is influenced by more than genetics and ageing. It is shaped by the whole body.
As research progresses, the gut–brain axis may become a key target for dementia prevention and early intervention - one that integrates nutrition, lifestyle, neurobiology and systems medicine.
References
Bajaj, J.S. et al. (2022) ‘The role of the gut microbiome in neurological disorders’, Nature Reviews Gastroenterology & Hepatology, 19(10), pp. 589–607.
Cryan, J.F. et al. (2019) ‘The microbiota–gut–brain axis’, Physiological Reviews, 99(4), pp. 1877–2013.
D’Amato, A. et al. (2020) ‘Gut microbiota and neurodegeneration: The role of shortchain fatty acids’, Nutrients, 12(3), p. 719.
Hou, Y. et al. (2023) ‘Gut microbiota in Alzheimer’s disease: A systematic review and metaanalysis’, Alzheimer’s & Dementia, 19(4), pp. 1234–1248.
Kowalski, K. and Mulak, A. (2019) ‘Brain–gut–microbiota axis in Alzheimer’s disease’, Journal of Neurogastroenterology and Motility, 25(1), pp. 48–60.
O’Toole, P.W. and Jeffery, I.B. (2015) ‘Gut microbiota and ageing’, Science, 350(6265), pp. 1214–1215.
Perry, V.H. and Holmes, C. (2014) ‘Microglial priming in neurodegenerative disease’, Nature Reviews Neurology, 10(4), pp. 217–224.
Sarkar, A. et al. (2016) ‘The role of the vagus nerve in the microbiota–gut–brain axis’, Journal of Physiology, 594(20), pp. 5777–5791.
Sudo, N. (2019) ‘Microbiome, HPA axis and stress’, Neuroscience & Biobehavioral Reviews, 105, pp. 199–212.
VallesColomer, M. et al. (2019) ‘The neuroactive potential of the human gut microbiota’, Nature Microbiology, 4(4), pp. 623–632.